Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
2,552
Views
4
CrossRef citations to date
0
Altmetric
Oncology
How accurate are the longer-term projections of overall survival for cancer immunotherapy for standard versus more flexible parametric extrapolation methods?
Miranda Coopera BresMed Health Solutions, Sheffield, UKhttps://orcid.org/0000-0001-8814-5500
, Sarah Smitha BresMed Health Solutions, Sheffield, UKhttps://orcid.org/0000-0003-3380-4411
, Troy Williamsb BresMed Health Solutions, Las Vegas, NV, USAhttps://orcid.org/0000-0002-1540-6922
& Raquel Aguiar-Ibáñezc Merck Canada Inc, Kirkland, CanadaCorrespondence[email protected]
https://orcid.org/0000-0002-3839-6966
https://orcid.org/0000-0002-3839-6966
Pages 260-273
|
Received 09 Sep 2021, Accepted 14 Jan 2022, Published online: 11 Feb 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.